Skip to content
Search

Latest Stories

Pharmacy bodies call on new health secretary to increase investment

Pharmacy bodies call on new health secretary to increase investment

Pharmacies are “ready and willing” to help the new government address the challenges the NHS faces 

Community Pharmacy England (CPE), the Company Chemists’ Association (CCA), the Independent Pharmacies Association (IPA), the National Pharmacy Association (NPA), and the Royal Pharmaceutical Society (RPS) have collaboratively written to the newly appointed health secretary, Wes Streeting, urging for increased investment in pharmacies to reduce GP waiting times.

Following Labour’s general election victory on 4 July, Streeting assumed the role of Secretary of State for Health and Social Care.


In their joint letter, the pharmacy bodies have conveyed their readiness and willingness to help the new government in addressing the challenges facing the NHS, provided there is sufficient funding, holistic workforce planning and improved medicines security.

They highlighted the importance of investing in community pharmacy to ensure “patient access to medicines, realising Labour’s vision of a return of the ‘family doctor’ and embedding a greater focus on prevention in the NHS.”

During the election campaign, Streeting acknowledged the significant funding challenges confronting community pharmacies, which have resulted in numerous closures.

Community Pharmacy England had previously expressed its intention to promptly schedule meetings with new government ministers to address the pressures on community pharmacies and to explore the implementation of the community pharmacy independent prescribing service promised in the Labour Party manifesto.

Janet Morrison, chief executive of CPE, highlighted that a top priority for the new government health team will be to conclude “negotiations on the 2024/25 Community Pharmacy Contractual Framework (CPCF).

“This is critical to assure the future for community pharmacies and the safe supply of medicines to patients, but it will be one item of many on their list of NHS crises to solve,: she said.

NPA Chief Executive Paul Rees mentioned that the Labour team has been informed about the decade-long financial cuts affecting pharmacies. He also noted that Streeting has expressed strong support for community pharmacies.

Streeting recently supported the NPA’s national day of action against pharmacy underfunding, stating that pharmacists across England have been "driven to desperation."

Acknowledging the scale of closures, Streeting  had told NPA that “Labour wants to reverse this shocking trend and put pharmacies at the forefront of our health service.”

Paul said: “Now he has to deliver - action is needed immediately to stop the pharmacy closures that are leaving many patients without convenient care close to home.”

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less